{"FinancialColumns":null,"FinancialHits":null,"TotalStockCount":0,"Securities":null,"OtcSecurities":null,"SortedSecurityCodes":null,"SearchId":"2ac7062f-556c-4ea5-bfd1-351b657a8f03","TotalCompanyCardCount":111,"Total":164,"Took":485,"DbTook":0,"Hits":[{"Id":"51264067","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"kLX1V2p2SOiJKak1InGmTA==","EncryptionKey":"a0xYMVYycDJTT2lKS2FrMUluR21UQT09","Title":"柳药股份：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"603368","StockTicker":"柳药股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207559027.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=kYKkPl1zlX2erjLszuV3X8OmMJonccaUxK/UIpzWd5xnC1y/eqw1kw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603368/2020-04-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 603368 \u0000 \u0000\t公司简称：\u0000 柳药股份 \u0000转债代码：\u0000 113563 \u0000 \u0000\t转债简称：柳药转债 \u0000<br />&emsp;&emsp;广西柳州医药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二〇二〇年四月二十二日\u0000<br />&emsp;&emsp;广西柳州医药股份有限公司 \u0000 2019 \u0000 年年度报告\u0000..."},"Highlight":{"Content":["《“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51259936","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"MXn4TY2FRYBvRyxS2Giw8Q==","EncryptionKey":"TVhuNFRZMkZSWUJ2Unl4UzJHaXc4UT09","Title":"康惠制药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"603139","StockTicker":"康惠制药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207555042.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=QKrNg8MhsYa2OArF52L6HntOGBsRxvG80aNgjXLaVCdpLw4K3CGhyg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603139/2020-04-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp; \u0000 陕西康惠制药股份有限公司 \u0000 201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603139 \u0000 \u0000 公司简称：\u0000 康惠制药\u0000<br />&emsp;&emsp;陕西康惠制药股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000211\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","群众的健康保健意识和健康需求日益提高。随着《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51262381","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"oVVckfUq4kkJEEMWRbDR9Q==","EncryptionKey":"b1ZWY2tmVXE0a2tKRUVNV1JiRFI5UT09","Title":"迪瑞医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"300396","StockTicker":"迪瑞医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207556598.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=b8HSdoocV84uautHivYFuCuvknQZoaUXh/Hah+H4lM7RIV+H1S+dvQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300396/2020-04-23 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300396 \t证券简称：迪瑞医疗\t公告编号：2020-042<br />&emsp;&emsp;迪瑞医疗科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@3@41@为鼓励我国医疗器械行业，尤其是诊疗设备行业的发展，国家先后出台了一系列行业鼓励政策。《国家中长期科学和技术发展规划纲要（2006-2020年）》将“研究预防和早期诊断关键技术，显著提高重大疾病诊断和防治能力”作为“人口与健康”重点领域的发展思路之一，“重点研究开发心脑血管病、肿瘤等重大疾病早期预警和诊断、疾病危险因素早期干预等关键技术”；“健康中国”被写入中共十八届五中全会《中共中央关于制定国民经济和社会发展第十三个五年规划的建议》公报；《“<em>健康中国2030</em>”规划纲要》提出引导发展专业的检验机构、提升医疗设备产业发展水平；国务院《关于实施健康中国行动的意见》进一步指导了未来十年全民疾病预防和健康促进的方向。2017年5月，国务院办公厅印发《深化医药卫生体制改革2017年重点工作任务》，按照“保基本、强基层、建机制”的改革要求，深化医疗、医保、医药联动改革，着力推进分级诊疗、现代医院管理、全民医保、药品供应保障、综合监管5项制度建设，2017年10月，中共中央办公厅、国务院办公厅发布《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》指出，改革临床试验管理，优化审评审批，加强创新权益保护，明确上市许可持有人的责任，提升技术支持的能力，为促进药品医疗器械产业结构调整和技术创新提供政策支持。2018年8月，国务院办公厅印发《深化医药卫生体制改革2018年下半年重点工作任务》，再次明确推进医疗器械国产化，促进创新产品应用推广。2018年11月，新版《创新医疗器械特别审批程序》完善了适用情形、细化了申请流程、提升了创新审查的时效性、完善了审查方式和通知形式，并明确对创新医疗器械的许可事项更优先办理。2019年7月，健康中国行动推进委员会发布《健康中国行动（2019—2030年）》，明确要求提升基层的筛查能力和仪器配置。2020年1月，新冠疫情爆发后，国家药品监督管理局按照《医疗器械应急审批程序》，加快了相关医疗器械的审批速度，有效满足了疫情防控需要，有助于后续体外诊断行业国产创新医疗器械的获批。与此同时，各地政府监管部门出台的关于“两票制”、“阳光采购”逐步实施，也会对行业的发展提出了新的要求，对于体外诊断企业而言，对其专业技术服务能力、业务的深度和广度也提出了更高的要求，促使传统的代理渠道模式向综合服务模式转变，市场集中度将快速提高，使体外诊断企业面临了新的发展机遇和挑战。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51262341","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Dh5/ermCJukuP/6S36hFUA==","EncryptionKey":"RGg1L2VybUNKdWt1UC82UzM2aEZVQT09","Title":"国脉科技：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-23T00:00:00","StockCode":"002093","StockTicker":"国脉科技","Url":"http://static.cninfo.com.cn/finalpage/2020-04-23/1207557322.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=DkgLAQZS52n+hbc51MQ3YtxOFNs9V9C/2pbiYU4wSSxr5LP49LCR4Q==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002093/2020-04-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"国脉科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;国脉科技股份有限公司\u0000<br />&emsp;&emsp;Guomai Technologies, Inc.\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51245686","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ErHzDSVADMFmPZx4h2OPFg==","EncryptionKey":"RXJIekRTVkFETUZtUFp4NGgyT1BGZz09","Title":"东宝生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-22T00:00:00","StockCode":"300239","StockTicker":"东宝生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-22/1207551882.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=JGD7uGmf4DuVCBsXlGnWRLc5pUasQS/gWGqO0AdcFIoCWw2nmXSbdA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300239/2020-04-22 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;包头东宝生物技术股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;包头东宝生物技术股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000019\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51260856","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"n9oBmuPdsiJRfZVRdZhmJw==","EncryptionKey":"bjlvQm11UGRzaUpSZlpWUmRaaG1Kdz09","Title":"汤臣倍健：2019年年度报告（更新后）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-22T00:00:00","StockCode":"300146","StockTicker":"汤臣倍健","Url":"http://static.cninfo.com.cn/finalpage/2020-04-22/1207555972.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sQS5RYYCMery+WH2RH6DLsENnC9UlJPPSSSB5FZL6i8ARdc8a8ENwA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300146/2020-04-22 2019年年度报告（更新后）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;汤臣倍健股份有限公司 \u0000 \u0000\t2019 \u0000年年度报告全文\u0000<br />证券代码：\u0000 300146 \u0000 证券简称：汤臣倍健 \u0000 \u0000 公告编号：\u0000 2020\u0000-\u00000\u000035\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告全文\u0000<br />&emsp;&emsp;1\u0000<br />&emsp;&emsp;汤臣倍健股份有限公司 \u0000 \u0000\t2019 \u0000年年度报告全文\u0000<br ..."},"Highlight":{"Content":["间轴，从战略上看趋势更重要、更清晰。<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>","年中共中央、国务院印发《“<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=sQS5RYYCMery+WH2RH6DLsENnC9UlJPPSSSB5FZL6i8ARdc8a8ENwA==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51224874","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"JxYEfi+Ll0nhqT7R5ig1Cw==","EncryptionKey":"SnhZRWZpK0xsMG5ocVQ3UjVpZzFDdz09","Title":"国发股份：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-21T00:00:00","StockCode":"600538","StockTicker":"国发股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-21/1207542355.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ZAfRsDfoV8jAhymlDKt33FOV5VsQyhE7UrZCUupdBbuax6aT6cv1rw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600538/2020-04-21 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;北海国发海洋生物产业股份有限公司 \u0000 201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600538 \u0000 \u0000 公司简称：\u0000 国发股份\u0000<br />北海国发海洋生物产业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000163\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51225851","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ypSf81d/prVs+dssMlOnsg==","EncryptionKey":"eXBTZjgxZC9wclZzK2Rzc01sT25zZz09","Title":"智飞生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-21T00:00:00","StockCode":"300122","StockTicker":"智飞生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-21/1207540059.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=tFW1hOtIYq/+4sR8GxM9iQYk8HbRiZakVMMqJ3F9+uaxwkhn04NJqA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300122/2020-04-21 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"重\u0000庆智飞生物制品\u0000股份有限\u0000公司 \u0000  \u0000\t2019 \u0000年\u0000年度报告全\u0000文\u0000<br />重庆智飞生物制品股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["被纳入国家战略，以及《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51226705","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"34lJ/7qMHoKr1LoQG7kwvw==","EncryptionKey":"MzRsSi83cU1Ib0tyMUxvUUc3a3d2dz09","Title":"盘龙药业：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-21T00:00:00","StockCode":"002864","StockTicker":"盘龙药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-21/1207540967.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=LY3FSydFlV8ZowXEDqcDsN/Ya4/K6KCl0S5Xj7XhNWSQLpwe+weX3A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002864/2020-04-21 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002864 \t证券简称：盘龙药业\t公告编号：2020-022<br />&emsp;&emsp;陕西盘龙药业集团股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@3@67@&emsp;&emsp;中国是医药行业全球最大的新兴市场，党的十九大报告提出“实施健康中国战略”，“坚持中西医并重，传承发展中医药事业”，以习近平同志为核心的党中央把中医药发展上升到国家发展战略高度，国家也先后出台了《中华人民共和国中医药法》《“<em>健康中国2030</em>”规划纲要》《中医药发展战略规划纲要（2016-2030）》、《中医药发展“十三五”规划》等一系列重磅文件，促进中国中医药事业不断发展壮大。2019年6月4日国务院印发了《国务院办公厅关于印发深化医药卫生体制改革2019年重点工作任务的通 知》中推动落实的重点工作，支持中医药事业传承创新发展，发挥中医药在治未病、重大疾病治疗、疾病 康复中的重要作用。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51226739","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ft7kRcxIXVkW4eBtU2x7vA==","EncryptionKey":"ZnQ3a1JjeElYVmtXNGVCdFUyeDd2QT09","Title":"盘龙药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-21T00:00:00","StockCode":"002864","StockTicker":"盘龙药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-21/1207540968.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=JKmQstbsSCWUSqa67S9zigeywQRwYSTVYBXPHLPR0ag2UNFcDMgfrA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002864/2020-04-21 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;陕西盘龙药业集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />陕西盘龙药业集团股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51174917","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"YncjzVsxGF93fMs1Fy3usQ==","EncryptionKey":"WW5janpWc3hHRjkzZk1zMUZ5M3VzUT09","Title":"灵康药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"603669","StockTicker":"灵康药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528905.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=8toIol2j8J75efHBLVypTGiUvmDE2RQGmfPPesC2WdxmdZ8OavVFZw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603669/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603669 \u0000 \u0000 公司简称：\u0000 灵康药业\u0000<br />&emsp;&emsp;灵康药业集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000195\u0000<br />"},"Highlight":{"Content":["随着“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51172174","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"31+JrtJlw8xZhNPF7ndeoQ==","EncryptionKey":"MzErSnJ0Smx3OHhaaE5QRjduZGVvUT09","Title":"健民集团：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"600976","StockTicker":"健民集团","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207524528.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=F/XgYeOmWWNDkwdBgn+rMAt8BlTXSk1IyOeq/AufU8aE/X77XO56oQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600976/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600976 \u0000 \u0000 公司简称：\u0000 健民集团\u0000<br />&emsp;&emsp;健民药业集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000213\u0000<br />"},"Highlight":{"Content":["战略全面推进，<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51175422","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"pPEdkps0KZ+Y8XMRi+Mu/A==","EncryptionKey":"cFBFZGtwczBLWitZOFhNUmkrTXUvQT09","Title":"新华医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"600587","StockTicker":"新华医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528239.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=maHLYC074xlaCjLpQawDoiYlD2Q7PpfXfu6gKgq79dLd52VlCDlqgw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600587/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 600587 \u0000 \u0000 公司简称：\u0000 新华医疗\u0000<br />山东新华医疗器械股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;二 \u0000 O \u0000 二 \u0000 O \u0000 年\u0000四\u0000月十\u0000八\u0000日 \u0000<br />&emsp;&emsp;重要提示 \u0000<br />"},"Highlight":{"Content":["技术等关键技术；《“<em>健康中国</em>","<em>2030</em>","康保障体系也是“<em>健康中国</em>","<em>2030</em>","@11@112@&emsp;&emsp;党的十九大报告与《<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=maHLYC074xlaCjLpQawDoiYlD2Q7PpfXfu6gKgq79dLd52VlCDlqgw==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51175423","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"rpF0bEgG/zv/SuejDmDVGw==","EncryptionKey":"cnBGMGJFZ0cvenYvU3VlakRtRFZHdz09","Title":"新华医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"600587","StockTicker":"新华医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207528228.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=DgCdAL/J/E7u3ExVSFoxLyOGekVw9WXBqyUN4ScZUzl+rkcKmM/fBw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600587/2020-04-18 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600587\t公司简称：新华医疗<br />山东新华医疗器械股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />&emsp;&emsp;二 O 二 O 年四月十八日<br />一 重要提示<br />"},"Highlight":{"Content":["@3@24@&emsp;&emsp;近年来，国家相继出台规划、指导措施等一系列扶持政策，促进医疗器械产业健康发展。《中国制造2025》明确把新材料、生物医药及高性能医疗器械作为重点发展的十大领域之一，提出提高医疗器械的创新能力和产业化水平，逐步摆脱高端医疗器械依赖进口的局面；《“十三五”国家科技创新规划》特别强调“十三五”时期将重点发展数字诊疗装备、体外诊断产品、健康促进关键技术、健康服务技术、养老助残技术等关键技术；《“<em>健康中国2030</em>”规划纲要》提出，未来15年，将深化医疗器械流通体制改革、强化医疗器械安全监管、加强高端医疗器械创新能力建设、推进医疗器械国产化。","@4@29@随着新医改的深入推进，国家逐步放开医疗市场准入，我国医疗服务覆盖的广度和深度都得到了明显提升，2019年全国总诊疗人次83.1亿人次，同比增长1.6%。截止2019年我国三项医疗保险参合人数达到13.4亿人，参保率达到了98.8%。完善健康保障体系也是“<em>健康中国2030</em>”中的重点内容。","@4@30@&emsp;&emsp;党的十九大报告与《<em>健康中国“2030</em>”规划纲要》中指出，要把人民健康放在优先发展的战略地位，促进医疗卫生体制改革创新，医疗服务行业开始进入一个新时代。2019年6 月12日，国家卫生健康委员会医政医管局发布《关于印发促进社会办医持续健康规范发展意见的通知》（国卫医发〔2019〕42 号），指出：加大政府支持社会办医力度。包括拓展社会办医空间、扩大用地供给、推广政府购买服务、落实税收优惠政策等4项措施。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51173188","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"dPVEdYkcflrWD3LoaJrMxw==","EncryptionKey":"ZFBWRWRZa2NmbHJXRDNMb2FKck14dz09","Title":"诚志股份：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-18T00:00:00","StockCode":"000990","StockTicker":"诚志股份","Url":"http://static.cninfo.com.cn/finalpage/2020-04-18/1207524881.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"化学原料及化学制品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Ew4vvGPGXiOWh9Jm6yCXYAkUWkwRbJgdJU14G5gpyEg7+jrknb6JXA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000990/2020-04-18 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;诚志股份\u0000有限公司 \u0000 2019 \u0000 年年度报告全文\u0000<br />&emsp;&emsp;201\u00009 \u0000 年度报告\u0000<br />&emsp;&emsp;201\u00009 \u0000 ANNUAL REPORT\u0000<br />&emsp;&emsp;二零二零\u0000年\u0000四\u0000月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51137917","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"r2Uf9oxOngeu5/MB6IRZSw==","EncryptionKey":"cjJVZjlveE9uZ2V1NS9NQjZJUlpTdz09","Title":"凯普生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-16T00:00:00","StockCode":"300639","StockTicker":"凯普生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-16/1207507515.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=hN3s0nhNTu91Wlkb9njGl4V2aJFE2e1WkKMsKfbWpUhdjrRsMuyZ0g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300639/2020-04-16 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广东凯普生物科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;广东凯普生物科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;（公告编号：\u0000 2\u0000020\u0000-\u00000\u000048\u0000）\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51135024","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Q60i/9FcFMi1LT3q3aCYiA==","EncryptionKey":"UTYwaS85RmNGTWkxTFQzcTNhQ1lpQT09","Title":"益盛药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-16T00:00:00","StockCode":"002566","StockTicker":"益盛药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-16/1207505408.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=VQumWvMc0AXot3dlYts3R2XkQszhY3s6yNnceNIcA4deGzfEAozFCQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002566/2020-04-16 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;吉林省集安益盛药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />吉林省集安益盛药业股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51135009","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"EC5Y2a7tmtGPChRRvEB+PQ==","EncryptionKey":"RUM1WTJhN3RtdEdQQ2hSUnZFQitQUT09","Title":"益盛药业：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-16T00:00:00","StockCode":"002566","StockTicker":"益盛药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-16/1207505407.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=mSfp6YyHxVcEHJ8SVRVMMXRWlfyfvFSzWrBy4PCVsrgHMyRK4FdZUw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002566/2020-04-16 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：002566\t证券简称：益盛药业\t公告编号：2020-008<br />&emsp;&emsp;吉林省集安益盛药业股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@42@&emsp;&emsp;医药行业的发展受到国民经济发展情况的影响，与人民生活质量存在较强的相关性。基于我国人口老龄化问题加剧、经济水平不断提高、人民健康意识不断提升以及国家对医药健康产业的重视和支持，我国医药行业保持稳健的增长态势。其中中医药是我国重要的卫生资源、优秀的文化资源、有潜力的经济资源、具有原创优势的科技资源。近年来，国家出台了一系列政策大力发展中医药产业。《“<em>健康中国2030</em>”规划纲要》明确提出，充分发挥中医药独特优势，提高中医药服务能力，推进中医药继承创新。随着我国社会经济的高速发展，城乡人民生活水平的不断提高，中国人口老龄化的不断加深及人民群众保健意识普遍增强，有预测表明到2020年中国健康产业产值将达到8万亿，到2030年达到16万亿元，成为国民经济的支柱性产业，而中医药大健康产业也将成21世纪最具发展潜力的产业之一。","@2@43@&emsp;&emsp;同时，近几年来国家先后出台的《中华人民共和国中医药法》、《“<em>健康中国2030</em>”规划纲要》、《中医药发展战略规划纲要（2016-2030）》、《中医药发展“十三五”规划》等一系列重磅文件，表明众多政策及规划均向中医药倾斜，这也将促使中医药大健康产业的大发展。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51119715","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"VXEio3815+wYdRcDutICyw==","EncryptionKey":"VlhFaW8zODE1K3dZZFJjRHV0SUN5dz09","Title":"三诺生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-15T00:00:00","StockCode":"300298","StockTicker":"三诺生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-15/1207499436.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=QTTj/U7dl8Lc6Nyslnde3ZmJBcFd0MXhep7ufdIf9pxVUmGMEhePQw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300298/2020-04-15 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;三诺生物传感股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />三诺生物传感股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51116810","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"rRK0LHsaJvZT2ImOLTpfJw==","EncryptionKey":"clJLMExIc2FKdlpUMkltT0xUcGZKdz09","Title":"莱茵生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-15T00:00:00","StockCode":"002166","StockTicker":"莱茵生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-15/1207498059.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=vvYeMeJASp3jTWoxmv99UDYsBfV+zDcxSfRRSkFnIEP2Pnq0gBm8Xg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002166/2020-04-15 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;桂林莱茵生物科技股份有限公司 \u0000 2019 \u0000年度报告全文\u0000<br />桂林莱茵生物科技股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51119655","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"kE0UDYRbuGx2an92QXBOxw==","EncryptionKey":"a0UwVURZUmJ1R3gyYW45MlFYQk94dz09","Title":"浙江震元：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-15T00:00:00","StockCode":"000705","StockTicker":"浙江震元","Url":"http://static.cninfo.com.cn/finalpage/2020-04-15/1207498393.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"批发业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=wGfOnDunEEugiPzucXlblgIcHPZJ7tjiqY+d3Resh47hrp/ePv6SVg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000705/2020-04-15 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"浙江震元股份有限公司\u0000<br />&emsp;&emsp;二〇一九\u0000年年度报告\u0000<br />&emsp;&emsp;浙江震元股份有限公司\u0000董事长： \u0000\t陈云伟\u0000<br /> \u0000 二〇二〇年四月十三\u0000日\u0000<br />&emsp;&emsp;浙江震元股份有限公司 \u0000 201\u00009 \u0000 年度报告\u0000<br />"},"Highlight":{"Content":["@23@287@&emsp;&emsp;近年来，国家出台了一系列政策大力发展中医药产业。其中，《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51091749","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"tpar08+CP/fe391qMWQ+9w==","EncryptionKey":"dHBhcjA4K0NQL2ZlMzkxcU1XUSs5dz09","Title":"昭衍新药：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-13T00:00:00","StockCode":"603127","StockTicker":"昭衍新药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-13/1207488162.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"研究和试验发展","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=9x04gDLFxudi732jKajmyZagEVKwxornOZyuBMC1xMa6lPxK6TZwvA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603127/2020-04-13 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603127 \u0000 \u0000 公司简称：\u0000 昭衍新药\u0000<br />北京昭衍新药研究中心股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000207\u0000<br />"},"Highlight":{"Content":["@16@201@&emsp;&emsp;我国政府已将患者安全作为《“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51091750","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"+ZpyXIYWsNR82oSkB6+Dqg==","EncryptionKey":"K1pweVhJWVdzTlI4Mm9Ta0I2K0RxZz09","Title":"昭衍新药：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-13T00:00:00","StockCode":"603127","StockTicker":"昭衍新药","Url":"http://static.cninfo.com.cn/finalpage/2020-04-13/1207488161.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"研究和试验发展","ParentIndustry":"科学研究和技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=POUDQqosQYVWXmsEykPf50kNkQxTxLI3SOH40gKbaU+ZZ5yy0YwWeg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603127/2020-04-13 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603127\t公司简称：昭衍新药<br />北京昭衍新药研究中心股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年..."},"Highlight":{"Content":["@8@95@&emsp;&emsp;我国政府已将患者安全作为《“<em>健康中国2030</em>”规划纲要》重要组成部分，中共中央办公厅国务院办公厅印发了《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》，国家药政管理部门出台了一系列的法规和技术指南，推动药物警戒工作与 ICH 国际指南接轨。为加强药品医疗器械全生命周期管理，落实上市许可人法律责任，2019年1月1日起实施的《关于药品上市许可持有人直接报告不良反应事宜的公告》（2018 年第 66 号），要求持有人应当建立健全药品不良反应监测体系。持有人是药品安全责任的主体，应当指定药品不良反应监测负责人，设立专门机构，"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51068393","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Qq6g2c3SF61wOMz2UTiWsA==","EncryptionKey":"UXE2ZzJjM1NGNjF3T016MlVUaVdzQT09","Title":"健康元：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-11T00:00:00","StockCode":"600380","StockTicker":"健康元","Url":"http://static.cninfo.com.cn/finalpage/2020-04-11/1207482742.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=KJAH35Dued1JBA8RIfwKJw3CaYwnDA00UbGNhmOpzMupA3AjA3YcoA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600380/2020-04-11 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"健康元药业集团 \u0000 \u0000\t2019 \u0000年年度报告\u0000<br />公司代码：\u0000 600380 \u0000  \u0000 公司简称：\u0000 健康元\u0000<br />&emsp;&emsp;健康元药业集团股份有限公司\u0000<br />&emsp;&emsp;600380\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51068819","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ioNrsru8DoGROboKobjc6A==","EncryptionKey":"aW9OcnNydThEb0dST2JvS29iamM2QT09","Title":"信立泰：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-11T00:00:00","StockCode":"002294","StockTicker":"信立泰","Url":"http://static.cninfo.com.cn/finalpage/2020-04-11/1207482673.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=+IVZUs0NudlCxug+8jOZdAz+eCXdpOULO+nirlAWWZufDasNRqVThQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002294/2020-04-11 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;深圳信立泰药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />深圳信立泰药业股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["面推进、<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51052449","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"c9YCsn54ZgcQN4AZnZ+nQg==","EncryptionKey":"YzlZQ3NuNTRaZ2NRTjRBWm5aK25RZz09","Title":"千金药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-10T00:00:00","StockCode":"600479","StockTicker":"千金药业","Url":"http://static.cninfo.com.cn/finalpage/2020-04-10/1207473983.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Bqnve4xrbeWkIqUZYbyS3B8W+fTvToz8so4Ky6X6mJs2wuAFk/V7DA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600479/2020-04-10 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600479 \u0000 \u0000 公司简称：\u0000 千金药业\u0000<br />&emsp;&emsp;株洲千金药业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000214\u0000<br />"},"Highlight":{"Content":["@58@727@&emsp;&emsp;国务院《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51052094","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"iQQNS461Lr8gngN2jJsdfA==","EncryptionKey":"aVFRTlM0NjFMcjhnbmdOMmpKc2RmQT09","Title":"鲁商发展：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-10T00:00:00","StockCode":"600223","StockTicker":"鲁商发展","Url":"http://static.cninfo.com.cn/finalpage/2020-04-10/1207473556.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"房地产业","ParentIndustry":"房地产业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=xqVnhKvu7k2qIm6jJKvrh0GZZDqtkmkhVa6WP31pkqbQqZl5he+wvQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600223/2020-04-10 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600223 \u0000 \u0000\t公司简称：\u0000 鲁商发展\u0000<br />鲁商健康产业发展股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000223\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51051316","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"eoQgCPoP2U7ceUnFA+o8ZQ==","EncryptionKey":"ZW9RZ0NQb1AyVTdjZVVuRkErbzhaUT09","Title":"戴维医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-10T00:00:00","StockCode":"300314","StockTicker":"戴维医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-04-10/1207471563.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Xvp1HNEk+ghLVTS3B7BYdisLla4EJ4C6KIaOAecAIrcVhaAJ//BBHg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300314/2020-04-10 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;宁波戴维医疗器械股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />宁波戴维医疗器械股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000015\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51040418","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"DNKcfyTWtSi/s8lNl+Xhbg==","EncryptionKey":"RE5LY2Z5VFd0U2kvczhsTmwrWGhiZz09","Title":"益丰药房：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"603939","StockTicker":"益丰药房","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207469045.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=MBC3BxXICyW3nLtPvFzyvfz09EL40dxmrDujUid6erk781tLkXmoPQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603939/2020-04-09 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"益丰大药房连锁股份有限公司 \u0000 \u0000 2019 \u0000年年度报告\u0000<br />公司代码：\u0000 603939 \u0000 \u0000 公司简称：\u0000 益丰药房\u0000<br />&emsp;&emsp;益丰大药房连锁股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000233\u0000<br />"},"Highlight":{"Content":["@14@216@&emsp;&emsp;随着“<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51040417","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"zg2XPegG94NxJvV4FEiAsA==","EncryptionKey":"emcyWFBlZ0c5NE54SnZWNEZFaUFzQT09","Title":"益丰药房：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"603939","StockTicker":"益丰药房","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207469046.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=ke+3h3/viHe/bOLW0WbAXm9AciSHrw8wZxsFdoancEUw65PL0MarEQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603939/2020-04-09 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：603939\t公司简称：益丰药房<br />益丰大药房连锁股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告..."},"Highlight":{"Content":["@6@52@&emsp;&emsp;随着“<em>健康中国</em> <em>2030</em>”战略和“十三五”深化医药卫生体制改革的持续推进，药品流通行业发展不断迈上新的台阶。根据中康 CMH 数据显示，2018 年零售终端全品类市场总体规模达 3,842 亿元，较2017年的3,664亿元增长4.9%；2018年全国药店门店数共计48.9万家，同比增长7.7%，增长速度创近5年新高，全国药店连锁化率达到52.15%，综合竞争力百强连锁企业的市场占有率达到 42.9%，药品零售市场规模和行业集中度持续提升，行业运行总体呈现：药品零售企业销售规模和连锁化率持续提高，线上线下融合发展的医药新零售模式不断涌现，医药物流运营效率及服务功能持续提升。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51040261","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"9doQjNczW3UDT0jXxX8oAg==","EncryptionKey":"OWRvUWpOY3pXM1VEVDBqWHhYOG9BZz09","Title":"陇神戎发：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"300534","StockTicker":"陇神戎发","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207468592.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jvzm3RdTl7qVNRI13GnUpi8pxr7fkMKzSHQTjlGrGBjchhcQxwHQ6w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300534/2020-04-09 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300534\t证券简称：陇神戎发\t公告编号：2020-028<br />&emsp;&emsp;甘肃陇神戎发药业股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@27@&emsp;&emsp;中医药在我国居民的健康生活中有重大影响，中医药在重大疾病防治中的优势、在“治未病”领域作用、在养生保健方面的特色逐渐得到社会的认可和重视。在我国医疗改革的大背景下，中医药作为医疗体系的重要组成部分，同样担负着遵循改革、深化改革的责任。2016年习近平总书记在首次卫生健康大会上的重要讲话，为中医药事业发展指明了方向。《“<em>健康中国2030</em>”规划纲要》将健康产业上升为国家战略，首部《中华人民共和国中医药法》、《中医药发展战略规划纲要（2016—2030年）》、《中国的中医药》白皮书的发布，全面开启了中医药事业健康发展的新征程。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51040257","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"tsaxsu9MihzgwQj8DSCWcw==","EncryptionKey":"dHNheHN1OU1paHpnd1FqOERTQ1djdz09","Title":"陇神戎发：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"300534","StockTicker":"陇神戎发","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207468597.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=UjPVuBpfiPP5ldVLyxxRyoOZDHVyicQEaqcfytlaJoKP8zqMOYG+SA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300534/2020-04-09 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;甘肃陇神戎发药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br /><br /><br />甘\u0000肃\u0000陇\u0000神\u0000戎\u0000发\u0000药\u0000业\u0000股\u0000份\u0000有\u0000限\u0000公\u0000司\u0000<br />2019 \u0000 年\u0000年\u0000度\u0000报\u0000告\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51039790","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"LNMyOdDXruXCxxz6SP7lAg==","EncryptionKey":"TE5NeU9kRFhydVhDeHh6NlNQN2xBZz09","Title":"启迪古汉：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"000590","StockTicker":"启迪古汉","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207468181.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sbon1lLM4FF6r+U4kRA8xnZA73YuYg1c7f4DUlA9ywlvsY0THOMktQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000590/2020-04-09 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;启迪古汉集团股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />启迪古汉集团股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />&emsp;&emsp;1 \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>","@27@344@&emsp;&emsp;随着《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51039779","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Ay8/N7gQz0K/wTwZLrpQbQ==","EncryptionKey":"QXk4L043Z1F6MEsvd1R3WkxycFFiUT09","Title":"启迪古汉：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-09T00:00:00","StockCode":"000590","StockTicker":"启迪古汉","Url":"http://static.cninfo.com.cn/finalpage/2020-04-09/1207468179.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=RjnCs+G9dAooExuRHL+9CoLOm7qYcS70TRrowFhWUZJz49LTR2wJdA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000590/2020-04-09 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：000590 \t证券简称：启迪古汉\t公告编号：2020-005<br />&emsp;&emsp;启迪古汉集团股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@37@&emsp;&emsp;随着“<em>健康中国2030</em>规划纲要”的落地，健康理念正在从以治病为中心向以健康为中心转变，医疗卫生投入将进一步加大，预计未来中国医药行业将继续呈现出良好的发展态势和巨大的发展潜力。具有研发创新能力、品牌优势以及具有整合能力的企业将在竞争中占据优势地位，具有高临床价值的产品将获得更大的市场空间，赢得行业和市场的认可。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"51028056","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ZW3weEZWuN5vU4ffmyUetg==","EncryptionKey":"Wlczd2VFWld1TjV2VTRmZm15VWV0Zz09","Title":"安科生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-08T00:00:00","StockCode":"300009","StockTicker":"安科生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-08/1207462725.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=0rHXgwnOjvqSu5bbgB476uJKse3Bkbj5txPqyySNRrQLgDMAltubLQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300009/2020-04-08 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;安徽安科生物工程\u0000(\u0000集团\u0000)\u0000股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />安徽安科生物工程\u0000(\u0000集团\u0000)\u0000股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;公告编号：\u0000 2020\u0000-\u0000015\u0000<br />2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50984001","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"EPnhp68seykaaqBpCQBy4Q==","EncryptionKey":"RVBuaHA2OHNleWthYXFCcENRQnk0UT09","Title":"卫宁健康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-04T00:00:00","StockCode":"300253","StockTicker":"卫宁健康","Url":"http://static.cninfo.com.cn/finalpage/2020-04-04/1207458678.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=q/UXoE9Ne0sN82RJYDTZ3BMVeQqpPG/YMUPX2qa2F0zPsCuv7TKtRw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300253/2020-04-04 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300253\t证券简称：卫宁健康\t公告编号：2020-025<br />&emsp;&emsp;卫宁健康科技集团股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@36@&emsp;&emsp;健康中国行动发布，国家战略全面推进落地：2019年7月15日，《国务院关于实施健康中国行动的意见》、《健康中国行动（2019—2030年）》等文件正式发布，从国家层面成立健康中国行动推进委员会，同时提出开展具体15项主要任务，实施疾病预防和健康促进的中长期行动。这是自2016年国家发布《“<em>健康中国2030</em>”规划纲要》后，进一步明确提出具体行动路径及落地规划，全面推动实现<em>健康中国2030</em>目标。以人民健康为核心，也是国家卫生健康事业长足发展的核心目标。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50968388","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"valiKrUb3nIN8x4xxamerQ==","EncryptionKey":"dmFsaUtyVWIzbklOOHg0eHhhbWVyUT09","Title":"同仁堂：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-03T00:00:00","StockCode":"600085","StockTicker":"同仁堂","Url":"http://static.cninfo.com.cn/finalpage/2020-04-03/1207452068.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=QwhtcVF19KOr9OA4AuKwLTowcVFjSd/dG1ZoKDgCWBxNqH4xP+GbMQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600085/2020-04-03 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600085 \u0000 \u0000 公\u0000司简称：\u0000 同仁堂\u0000<br />&emsp;&emsp;北京同仁堂股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000183\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50969316","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"bHJFl6XJvM5fSwaJveNgBA==","EncryptionKey":"YkhKRmw2WEp2TTVmU3dhSnZlTmdCQT09","Title":"利德曼：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-03T00:00:00","StockCode":"300289","StockTicker":"利德曼","Url":"http://static.cninfo.com.cn/finalpage/2020-04-03/1207452649.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=TJarZVXSIYCDRSq0B3YcDNx3IG3ht9qKZth7A0kZFi63w6eSVuN62g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300289/2020-04-03 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;北京利德曼生化股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />北京利德曼生化股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u00000\u000012\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 04 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50969313","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"hchBataUPqaIs5gzCJemMg==","EncryptionKey":"aGNoQmF0YVVQcWFJczVnekNKZW1NZz09","Title":"利德曼：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-03T00:00:00","StockCode":"300289","StockTicker":"利德曼","Url":"http://static.cninfo.com.cn/finalpage/2020-04-03/1207452646.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=LwfagCO35ITziGdW4apRIBBe+Os34rKBscS7+LEi5BSFKWPTf5V5qQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300289/2020-04-03 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300289\t证券简称：利德曼\t公告编号：2020-013<br />&emsp;&emsp;北京利德曼生化股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@4@57@&emsp;&emsp;《“<em>健康中国2030</em>”规划纲要》、《“十三五”生物产业发展规划》、《“十三五”医疗器械科技创新专项规划》等文件明确提出：提高高端医疗设备市场的国产化率，促进进口替代，推进体外诊断产品的自动化、智能化进程。国家产业政策的逐步实施，助力我国体外诊断行业长期可持续发展，为我国体外诊断行业的发展创造了良好的外部环境。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50953560","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"r3Boh5uD2lrtO90adEiW/A==","EncryptionKey":"cjNCb2g1dUQybHJ0TzkwYWRFaVcvQT09","Title":"寿仙谷：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-02T00:00:00","StockCode":"603896","StockTicker":"寿仙谷","Url":"http://static.cninfo.com.cn/finalpage/2020-04-02/1207446308.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=gTBiHw/LbejXruqdTQBfPf6KAo4pcjbp7Ut+p3jKfdxmgrvwW861Zg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603896/2020-04-02 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：\u0000 603896 \u0000 \u0000 公司简称：\u0000 寿仙谷\u0000<br />浙江寿仙谷医药股份有限公司 \u0000<br />&emsp;&emsp;Zhejiang \u0000 Shouxiangu \u0000 Pharmaceutical \u0000 Co., \u0000 Ltd.\u0000<br />&emsp;&emsp;（浙江省\u0000武义县壶山街道商城路 \u0000 10 \u0000号\u0000）\u0000<br />2019 \u0000 年年度报告 \u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50953924","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"e6JnhKpp6EDUqBdMgUreiA==","EncryptionKey":"ZTZKbmhLcHA2RURVcUJkTWdVcmVpQT09","Title":"天坛生物：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-04-02T00:00:00","StockCode":"600161","StockTicker":"天坛生物","Url":"http://static.cninfo.com.cn/finalpage/2020-04-02/1207447441.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=iMBstk4a9Ge0m7yk3USC0W4UhFgGWvXgJAbU1cabIEDNBbyGpD1e6A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600161/2020-04-02 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600161 \u0000  \u0000 公\u0000司\u0000简称：\u0000 天坛生物\u0000<br />北京天坛生物制品股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度\u0000报告 \u0000<br />&emsp;&emsp;1\u0000/\u0000210\u0000<br />"},"Highlight":{"Content":["把握建设“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-57481","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"t2GH3b30UosquLMkD1FbnA==","EncryptionKey":"dDJHSDNiMzBVb3NxdUxNa0QxRmJuQT09","Title":"南微医学：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"688029","StockTicker":"南微医学","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207428734.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=mDlwRUriKd6R1bizEFxQT/vZ7fY6/Nktr7qPOvKgffukudy+deyNMg==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688029/2020-03-31 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688029\t公司简称：南微医学<br />南微医学科技股份有限公司<br />&emsp;&emsp;2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@51@430@&emsp;&emsp;（1）行业持续景气成为大趋势。医疗技术快速发展，让人民群众及时接受具有临床价值或成本效率优势的新医疗技术服务，是医疗保障工作的重要内容之一。从公司主要产品的适应证来看，恶性肿瘤是我国人民健康的“头号杀手”，其中消化道肿瘤发病率占到成人肿瘤发病率半数以上，严重威胁国人生命健康。《“<em>健康中国2030</em>”规划纲要》提出了“到2030年，总体癌症5年生存率提高15%”的目标，为实现此目标，消化道肿瘤防治工作已成为重中之重。而中国胃肠镜检查的渗透率远远低于美国、日本等发达国家。随着人口老龄化的到来，政府对健康事业的持续推动，人民群众健康意识的增强，内镜检查将成为适龄人群的主流刚需，在较长时间里持续上升且不受季节性周期性影响。从国外情况看，美国、欧洲、日本及新兴国家对内镜下微创诊疗器械的需求较大且保持不同程度增长，行业景气度具有可持续性。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50921864","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"M4CHxILmf6R9vbA9nVDj3A==","EncryptionKey":"TTRDSHhJTG1mNlI5dmJBOW5WRGozQT09","Title":"康德莱：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"603987","StockTicker":"康德莱","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207432988.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=UfBS0vKxdx9lHlr8o6rTFr84s/O3jnOTo1Squ9G2KTI0Wxzwqa+HqA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/603987/2020-03-31 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 603987 \u0000 \u0000\t公司简称：\u0000 康德莱\u0000<br />上海康德莱企业发展集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000266\u0000<br />"},"Highlight":{"Content":["@36@372@局面。《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50917983","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"4Yi5G/1gQ3cV/aeMEuxb7A==","EncryptionKey":"NFlpNUcvMWdRM2NWL2FlTUV1eGI3QT09","Title":"昆药集团：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"600422","StockTicker":"昆药集团","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207430383.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=9yrypKE8WxolYLsdzD3mD6cDvGrZ3eOa75JoGD955W22qf634Nes4g==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600422/2020-03-31 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600422 \u0000 \u0000 公司简称：\u0000 昆药集团\u0000<br />&emsp;&emsp;昆药集团股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000273\u0000<br />"},"Highlight":{"Content":["受众人群广泛。近年来，国家对中医药发展始终坚持扶持与规范并重原则，此前已发布的《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50917984","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"pYXiaMenRbggBwb/mTdSLw==","EncryptionKey":"cFlYaWFNZW5SYmdnQndiL21UZFNMdz09","Title":"昆药集团：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"600422","StockTicker":"昆药集团","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207430394.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=3I1RcSoHXG1Gm/0S1uTwG9HN6jkeF93y3JISkzQrrJp6MgHQHfnUfA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600422/2020-03-31 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600422\t公司简称：昆药集团<br />昆药集团股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的..."},"Highlight":{"Content":["@5@35@中医药在预防、治疗康复领域将发挥重要作用。中医中药有几千年文化的传承，具备深厚的社会文化基础，受众人群广泛。近年来，国家对中医药发展始终坚持扶持与规范并重原则，此前已发布的《“<em>健康中国</em> <em>2030</em>”规划纲要》、《中医药发展“十三五”规划》、《中医药发展规划纲要（2016-2030）》一系列政策性文件及《中医药法》均对中医药发展给予积极引导和推动，2019年发布的《中共中央国务院关于促进中医药传承创新发展的意见》及《<中共中央国务院关于促进中医药传承创新发展的意见>重点任务分工方案》更为中医药在新时代的传承创新发展提供了纲领性的指导，使中药行业政策渐趋明朗。未来，中医药将聚焦心血管、肿瘤、骨骼、慢性呼吸系统、糖尿病等疾病领域，充分发挥其独特优势，在慢病的预防、诊疗和康复阶段发挥重要作用，守护百姓全生命周期健康，中医药尤其中医药大健康产业前景广阔；而公司作为主要参与者的“青蒿素”研究成果获得诺贝尔生理学或医学奖也为中医药的科研创新及发展路径带来启示，多学科、跨行业、海内外合作将为加快中医药现代化发展带来广阔空间。与此同时，受中药注射剂面临严格管控、中药饮片加成面临取消等影响，中药行业或将面临洗牌，只有具备产品优势、重视新药研发和品种培育、拓展消费领域的中药企业或将有望在行业变局中赢得竞争优势。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50919736","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"9yXDFbdN2NXxjLJB84jXFQ==","EncryptionKey":"OXlYREZiZE4yTlh4akxKQjg0alhGUT09","Title":"神思电子：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"300479","StockTicker":"神思电子","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207431063.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"计算机、通信和其他电子设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=1/DpZs5lSaZK7q+BHnQ1hLg4I1YpPlz1WdR7CokaTTRIhF3ctBT3Gw==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300479/2020-03-31 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300479\t证券简称：神思电子\t公告编号：2020-010<br />&emsp;&emsp;神思电子技术股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@5@63@&emsp;&emsp;公司响应《“<em>健康中国</em> <em>2030</em>”规划纲要》、《国民营养计划（2017-2030）》国家战略，秉承“人工智能+大数据+营养健康”的设计理念，采用精准计量、人脸识别、大数据营养分析、视频分析等一系列先进技术赋能传统餐厅进行智慧化升级。针对就餐者，实现刷脸就餐、自助取餐、自动计量扣费并推送营养分析、饮食及运动建议。针对餐厅管理者，系统提供智慧餐厅管理以及后厨行为分析服务，实现进销存管理、智能排菜、智能分单与后厨规范化监管等功能。该系统平台基于云服务架构设计，可以依据客户要求进行快速灵活部署。报告期内，智慧餐饮已在多省区机关、企业、高校食堂商用，并且入选2019年度企业食堂信息化服务商全国TOP10，通过华为技术认证，加入鲲鹏生态。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50920233","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"foGeQU7CZfUAxDBcH+oBgg==","EncryptionKey":"Zm9HZVFVN0NaZlVBeERCY0grb0JnZz09","Title":"乐普医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-31T00:00:00","StockCode":"300003","StockTicker":"乐普医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-31/1207431493.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=hDyk87u0IK4mZ0RLhp2T+Kys7Yk8n5gCubdC5UpC3xVmuGONG1MXMQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300003/2020-03-31 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;乐普（北京）医疗器械股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;乐普（北京）医疗器械股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000038\u0000<br />&emsp;&emsp;20\u000020\u0000年\u000003\u0000月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"kcb-57394","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"hYYVqgK2SVdwXYQqK4RU7A==","EncryptionKey":"aFlZVnFnSzJTVmR3WFlRcUs0UlU3QT09","Title":"心脉医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-30T00:00:00","StockCode":"688016","StockTicker":"心脉医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-30/1207423495.PDF","MarketType":5,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=1RAOI2PmNhOr1LOLG9NAKQJfTejcuZ7GnVYV8TsH9nk5+ULJ3DFTKA==&sector=1","ShareHref":null,"SourcePath":"kcb-filings/original/688016/2020-03-30 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：688016\t公司简称：心脉医疗<br />上海微创心脉医疗科技股份有限公司<br />&emsp;&emsp;2019 年年度报告<br />&emsp;&emsp;重要提示<br />一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整，<br />"},"Highlight":{"Content":["@37@403@&emsp;&emsp;我国医疗器械行业的发展作为我国人民生命健康和医疗卫生事业的重要组成部分，得到国家的高度重视。《“<em>健康中国2030</em>”规划纲要》和《中国制造2025》都将医疗器械发展提升至国家发展战略地位。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50870511","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"1bYoFtS6Z7qgHAXbcr4ZEQ==","EncryptionKey":"MWJZb0Z0UzZaN3FnSEFYYmNyNFpFUT09","Title":"开开实业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-28T00:00:00","StockCode":"600272","StockTicker":"开开实业","Url":"http://static.cninfo.com.cn/finalpage/2020-03-28/1207419133.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"零售业","ParentIndustry":"批发和零售业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=xzKt4eFnDR4Qdnz/OeUVPiOzADjASzB3hcLzy7AwwSj1cQDby5eNHg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600272/2020-03-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600272 \u0000900943 \u0000\t公司简称：\u0000 开开实业 \u0000 开开 \u0000 B \u0000 股\u0000<br />.\u0000<br />&emsp;&emsp;上海开开实业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />"},"Highlight":{"Content":["@27@355@&emsp;&emsp;在“<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50868727","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"VByyRLYAh3byFgxCage9Cg==","EncryptionKey":"VkJ5eVJMWUFoM2J5Rmd4Q2FnZTlDZz09","Title":"太龙药业：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-28T00:00:00","StockCode":"600222","StockTicker":"太龙药业","Url":"http://static.cninfo.com.cn/finalpage/2020-03-28/1207417192.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=XwnYG8rgVvFdgz9JeDoEwEepwyC04ifDg/3prnRvm9eZp3pSUJL13A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600222/2020-03-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"公司代码：600222\t公司简称：太龙药业<br />河南太龙药业股份有限公司<br />&emsp;&emsp;2019 年年度报告摘要<br />一 重要提示<br />1 本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到上海证券交易所网站等中国证监会指定媒体上仔细阅读年度报告全文。2 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内..."},"Highlight":{"Content":["@5@46@&emsp;&emsp;继《中医药法》、《<em>健康中国“2030</em>”》等鼓励中医药产业发展的政策实施后，2019年10月中共中央、国务院《关于促进中医药传承创新发展的意见》再次将中医药提升到国家战略高度；同时第 72 届世界卫生大会首次将起源于中医药的传统医学正式纳入国际疾病分类；国内、国际对中医药的发展日益重视，中医药产业将迎来发展新机遇。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50871220","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"8Zf6dNVP32VtsJ0dzH5xCw==","EncryptionKey":"OFpmNmROVlAzMlZ0c0owZHpINXhDdz09","Title":"三鑫医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-28T00:00:00","StockCode":"300453","StockTicker":"三鑫医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-28/1207419289.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=T70Se2WfNKeQnpLDMrGeHzmc1MG1W2nTo507axfV1nUEtmnMp6HFbg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300453/2020-03-28 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300453\t证券简称：三鑫医疗\t公告编号：2020-024<br />&emsp;&emsp;江西三鑫医疗科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />大信会计师事务所（特殊普通合伙）对本年度公司财务报告的审计意..."},"Highlight":{"Content":["@9@77@&emsp;&emsp;（1）全面实施《“<em>健康中国2030</em>”规划纲要》","@9@78@&emsp;&emsp;2019年7月，国务院印发了《健康中国行动（2019—2030年）》、《关于实施健康中国行动的意见》、《关于成立健康中国行动推进委员会的通知》等一系列重要文件并明确提出，要“加快推动从以治病为中心转变为以人民健康为中心，动员全社会落实预防为主方针，实施健康中国行动，提高全民健康水平”。《“<em>健康中国2030</em>”规划纲要》指出，到2030年，药品、医疗器械质量标准全面与国际接轨”。“全面建立成熟完善的分级诊疗制度，形成基层首诊、双向转诊、上下联动、急慢分治的合理就医秩序，健全治疗-康复-长期护理服务链。”而分级诊疗的核心目的在于医疗资源逐步下沉、吸引患者选择基层医疗机构就诊。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50871218","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"B9yWXBzOgKXMyM0X6grxYQ==","EncryptionKey":"Qjl5V1hCek9nS1hNeU0wWDZncnhZUT09","Title":"三鑫医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-28T00:00:00","StockCode":"300453","StockTicker":"三鑫医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-28/1207419292.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=Ey0XzmlFHl8sXPNtpII8sy5pmc4FvnIFqcIhU9K+41uCEkkqtW2rOQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300453/2020-03-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;江西三鑫医疗科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />江西三鑫医疗科技股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;2020\u0000-\u0000023 \u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 03 \u0000 月 \u0000<br />"},"Highlight":{"Content":["）全面实施《“<em>健康中国</em>","<em>2030</em>","全社会落实预防为主方针，实施健康中国行动，提高全民健康水平”。《“<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50869273","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"rJNKGOTyodRuAF09vw7jgA==","EncryptionKey":"ckpOS0dPVHlvZFJ1QUYwOXZ3N2pnQT09","Title":"恩华药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-28T00:00:00","StockCode":"002262","StockTicker":"恩华药业","Url":"http://static.cninfo.com.cn/finalpage/2020-03-28/1207417378.PDF","MarketType":3,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=2OVomqvA1Ric9QbadR/2SJX/w1IO30Ob3LoVAzRHmV+y8pG5vkObgg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/002262/2020-03-28 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;江苏恩华药业股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />江苏恩华药业股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />2020 \u0000 年 \u0000 03 \u0000 月\u0000<br />&emsp;&emsp;1\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50841247","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"+y5pwOVVh6ROlDCnHHgyVQ==","EncryptionKey":"K3k1cHdPVlZoNlJPbERDbkhIZ3lWUT09","Title":"创业慧康：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-26T00:00:00","StockCode":"300451","StockTicker":"创业慧康","Url":"http://static.cninfo.com.cn/finalpage/2020-03-26/1207404449.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=sVJylRC7LDdHRwXEstIAvudMl6fxHo9cDGgrxoWsHqo4rC6L+JK9Ww==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300451/2020-03-26 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"创\u0000业\u0000慧\u0000康\u0000科\u0000技\u0000股\u0000份\u0000有\u0000限\u0000公\u0000司 \u0000 2\u00000\u00001\u00009 \u0000年\u0000年\u0000度\u0000报\u0000告\u0000全\u0000文\u0000<br />&emsp;&emsp;创\u0000业\u0000慧\u0000康\u0000科\u0000技\u0000股\u0000份\u0000有\u0000限\u0000公\u0000司\u0000<br />&emsp;&emsp;2\u00000\u00001\u00009 \u0000 年\u0000年\u0000度\u0000报\u0000告\u0000<br />&emsp;&emsp;公\u0000告\u0000编\u0000号\u0000：\u0000 2\u00000\u00002\u00000\u0000-\u00000\u00002\u00009\u0000<br />&emsp;&emsp;2\u00000\u00002\u00000 ..."},"Highlight":{"Content":["@43@539@2015年\t国务院\t年，实现全员人口信息、电子 健康档案和电子病历三大数据库基本覆盖全国人口并信息动态更新，《全国医疗卫生服务体系规划纲要（2015-2020年）》提出加强人口健康信息化建设，到2020全面建成互联互通的国家、省、市、县四级人口健康信息平台。<hr style='margin:2px; border:none;' />2016年\t中共中央、国务院\t《“<em>健康中国2030</em>”规划纲要》，首次将有关健康医疗产业的纲要提高至国家层级的战略，纲要明确提出到2020年健康服务业总规模达到8万亿，到2030年达到16万亿，行业前景极其广阔。<hr style='margin:2px; border:none;' />"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50841251","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"rtgXZ/JhrW+DgLRkvg/5Zw==","EncryptionKey":"cnRnWFovSmhyVytEZ0xSa3ZnLzVadz09","Title":"创业慧康：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-26T00:00:00","StockCode":"300451","StockTicker":"创业慧康","Url":"http://static.cninfo.com.cn/finalpage/2020-03-26/1207404444.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"软件和信息技术服务业","ParentIndustry":"信息传输、软件和信息技术服务业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=8xsuBJ6iv+MnG8JNdafaCK53SDiqYKLbRv8FfVKwPreiT/7h08ZQPg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300451/2020-03-26 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300451 \t证券简称：创业慧康\t公告编号：2020-030<br />&emsp;&emsp;创业慧康科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />董事、监事、高级管理人员异议声明<br />"},"Highlight":{"Content":["@2@25@&emsp;&emsp;近年，在《“<em>健康中国2030</em>”规划纲要》、《“十三五”全国人口健康信息化发展规划》等新政策导向下，公司紧跟产业步伐，顺应行业的发展，结合自身市场拓展、业务特点及产品服务优势，组建了医卫信息化事业群、医卫物联网事业群、医卫互联网事业群加医保事业部的公司业务新格局，为公司医疗健康大数据运营、健康城市建设运营、互联网医院建设运营、智慧医疗物联网服务运维、智慧医保等创新业务进一步发展奠定了坚实的基础。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50801982","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"hLo1fr56nrjZSF4N9XveeQ==","EncryptionKey":"aExvMWZyNTZucmpaU0Y0TjlYdmVlUT09","Title":"中国太保：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-23T00:00:00","StockCode":"601601","StockTicker":"中国太保","Url":"http://static.cninfo.com.cn/finalpage/2020-03-23/1207391499.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"保险业","ParentIndustry":"金融业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=y7cjfaiJ/h/657bcLldO+S7d59VrV7zlKb0WXXSVjSQ3V0CNeucKtQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/601601/2020-03-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;2019 \u0000 年度报告\u0000<br />&emsp;&emsp;Annual Report\u0000<br />&emsp;&emsp;（\u0000股票代码：\u0000 60160\u00001\u0000）\u0000<br />&emsp;&emsp;责任、智慧、温度 \u0000<br />&emsp;&emsp;中国太保 全力抗疫\u0000<br />"},"Highlight":{"Content":["充实专业团队，通过倾斜性施策手段持续让惠于贫困人口，以卓有成效的精准扶贫成果，助推“乡村振兴”战略和<em>健康中国</em>“","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50801919","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"pqI6DLved7C6ResJ4ja/nQ==","EncryptionKey":"cHFJNkRMdmVkN0M2UmVzSjRqYS9uUT09","Title":"新诺威：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-23T00:00:00","StockCode":"300765","StockTicker":"新诺威","Url":"http://static.cninfo.com.cn/finalpage/2020-03-23/1207390439.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=xBi1ifcTGTgXE/t2NFg8jNfztDsd+/dj1EZkfHm26LKMF/QvdQ+jfA==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300765/2020-03-23 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"证券代码：300765 \t证券简称：新诺威\t公告编号：2020-012<br />&emsp;&emsp;石药集团新诺威制药股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />信永中和会计师事务所（特殊普通合伙）对本年度公司财务报告的..."},"Highlight":{"Content":["@4@61@&emsp;&emsp;面对保健食品行业的变化，公司对保健食品行业深入思考与定位，为零售行业实践出一条发展路径，提升行业专业能力，为消费者提供深度服务，从而提升行业经营效益。“<em>健康中国2030</em>”规划纲要指出，“预防为主、关口前移，推行健康生活方式，减少疾病发生，促进资源下沉，实现可负担、可持续的发展”。保健食品品行业是健康产业的重要组成部分，目前中国市场是仅次于美国的全球第二大保健营养品市场，但保健食品的人均渗透率与欧美等发达国家相比仍处于较低水平，未来中国保健食品市场还有着广阔的潜力。"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50801917","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"T8BG5tEvA+8Iewo/0rFDPA==","EncryptionKey":"VDhCRzV0RXZBKzhJZXdvLzByRkRQQT09","Title":"新诺威：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-23T00:00:00","StockCode":"300765","StockTicker":"新诺威","Url":"http://static.cninfo.com.cn/finalpage/2020-03-23/1207390442.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=MmJ201iIVImtOqVWCR+i4t89cITasq8OsUgstWJBwcQskepzdDEzxg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300765/2020-03-23 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;石药集团新诺威制药股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />石药集团新诺威制药股份有限公司\u0000<br />2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;2020\u0000-\u0000011\u0000<br />2020 \u0000 年 \u0000 03 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”","<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50784983","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"Ho/6NzB6sTjEQNSelRQqcA==","EncryptionKey":"SG8vNk56QjZzVGpFUU5TZWxSUXFjQT09","Title":"江中药业：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-21T00:00:00","StockCode":"600750","StockTicker":"江中药业","Url":"http://static.cninfo.com.cn/finalpage/2020-03-21/1207390546.PDF","MarketType":1,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=mwOWb+VUt4r0kOO04bE951GqFvd5uulEDIuk0WsWZOn8jmXidpHKSg==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/600750/2020-03-21 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;201\u00009 \u0000年年度报告\u0000<br />公司代码：\u0000 600750 \u0000 \u0000 公司简称：\u0000 江中药业\u0000<br />&emsp;&emsp;江中药业股份有限公司 \u0000<br />&emsp;&emsp;2019 \u0000 年年度报告 \u0000<br />&emsp;&emsp;1 \u0000/ \u0000193\u0000<br />"},"Highlight":{"Content":["《中医药法》、《<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50771012","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"MJocz0RzH6LQBcWrzpN2ug==","EncryptionKey":"TUpvY3owUnpINkxRQmNXcnpwTjJ1Zz09","Title":"华润三九：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-20T00:00:00","StockCode":"000999","StockTicker":"华润三九","Url":"http://static.cninfo.com.cn/finalpage/2020-03-20/1207387542.PDF","MarketType":2,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=8/G28yzUDMjyLP3I5mVOZTy525JpHDkHnXujFAHkxkg5O7MnMp+VdQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/000999/2020-03-20 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;华润三九医药股份有限公司 \u0000 2019 \u0000年年度报告\u0000<br />&emsp;&emsp;1\u0000<br />&emsp;&emsp;华润三九医药股份有限公 \u0000 2019 \u0000 年年度报告 \u0000 2020 \u0000 年 \u0000 0\u00003 \u0000 月\u0000<br />&emsp;&emsp;华润三九医药股份有限公司 \u0000 2019 \u0000年年度报告\u0000<br />&emsp;&emsp;第一节重要提示、目录和释..."},"Highlight":{"Content":["@13@106@&emsp;&emsp;随着“<em>健康中国</em>","<em>2030</em>","@32@324@&emsp;&emsp;随着《<em>健康中国</em>","<em>2030</em>","@34@338@&emsp;&emsp;中医药具有悠久的历史，在慢病预防和康复阶段具有独特优势。《<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=8/G28yzUDMjyLP3I5mVOZTy525JpHDkHnXujFAHkxkg5O7MnMp+VdQ==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50683058","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"ihe5k9H884WemHu1uPQE5A==","EncryptionKey":"aWhlNWs5SDg4NFdlbUh1MXVQUUU1QT09","Title":"汤臣倍健：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-13T00:00:00","StockCode":"300146","StockTicker":"汤臣倍健","Url":"http://static.cninfo.com.cn/finalpage/2020-03-13/1207368915.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"食品制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jVEz47virxkHsejjRfd6JTRIc0OftX1IgdFPexqSh4yQM61MHJYq5w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300146/2020-03-13 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;汤臣倍健股份有限公司 \u0000 \u0000\t2019 \u0000年年度报告全文\u0000<br />证券代码：\u0000 300146 \u0000 \u0000 证券简称：汤臣倍健 \u0000 \u0000 公告编号：\u0000 2020-014\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告全文\u0000<br />&emsp;&emsp;披露日期：\u0000 2\u0000020 \u0000 年 \u0000 3 \u0000 月 \u0000 13 \u0000 日\u0000<br />&emsp;&emsp;1\u0000..."},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<em>2030</em>","<em>健康中国</em>","<center><a target=\"_blank\" href=\"/Home/FilingDetail?key=jVEz47virxkHsejjRfd6JTRIc0OftX1IgdFPexqSh4yQM61MHJYq5w==&sector=1\"><b>更多匹配结果...</b></a></center>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":true,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50681303","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"JMeA/f/a1k9GEFjzkqV1ag==","EncryptionKey":"Sk1lQS9mL2ExazlHRUZqemtxVjFhZz09","Title":"香雪制药：2017年年度报告（更新后）","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-12T00:00:00","StockCode":"300147","StockTicker":"香雪制药","Url":"http://static.cninfo.com.cn/finalpage/2020-03-12/1207368148.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"医药制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=witeJ+5tBaM3QzCL7730/LY6g2sqC4wnuaMwo8GLlPicqAZC3JVU3A==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300147/2020-03-12 2017年年度报告（更新后）.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广州市香雪制药股份有限公司 \u0000 2017 \u0000年年度报告全文\u0000<br />广州市香雪制药股份有限公司\u0000<br />&emsp;&emsp;2017 \u0000 年年度报告\u0000<br />&emsp;&emsp;2018\u0000-\u00000\u000019\u0000<br />&emsp;&emsp;2018 \u0000 年 \u0000 03 \u0000 月\u0000<br />"},"Highlight":{"Content":["<em>健康中国</em>","<em>2030</em>”"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50602906","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"HM4pDThwdBx2Q/cs4jUoiw==","EncryptionKey":"SE00cERUaHdkQngyUS9jczRqVW9pdz09","Title":"阳普医疗：2019年年度报告","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-07T00:00:00","StockCode":"300030","StockTicker":"阳普医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-07/1207351517.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=dAuTpyoicrHKguNLBLcCJ8+Gf1VPdd9Ucb01wwrWmWhC+UzfITbN8w==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300030/2020-03-07 2019年年度报告.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"&emsp;&emsp;广州阳普医疗科技股份有限公司 \u0000 2019 \u0000年年度报告全文\u0000<br />&emsp;&emsp;广州阳普医疗科技股份有限公司\u0000<br />&emsp;&emsp;2019 \u0000 年年度报告\u0000<br />&emsp;&emsp;公告编号：\u0000 2020\u0000-\u0000017\u0000<br />&emsp;&emsp;2020 \u0000 年 \u0000 0\u00003 \u0000 月\u0000<br />"},"Highlight":{"Content":["慧医疗产业生态链平台型公司，深耕智慧医疗行业，紧紧围绕<em>健康中国</em>","<em>2030</em>"],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]},{"Id":"50602907","Sector":0,"Source":{"DocumentId":null,"DocumentKey":null,"Label":null,"Id":null,"Key":"HL3oonYyzCMkfRkx7tPbgA==","EncryptionKey":"SEwzb29uWXl6Q01rZlJreDd0UGJnQT09","Title":"阳普医疗：2019年年度报告摘要","Attachments":[],"Paragraphs":[],"EngParagraphs":[],"UnigramParagraphs":[],"Pages":[],"QaPairs":[],"SubTitles":[],"PublishDate":"2020-03-07T00:00:00","StockCode":"300030","StockTicker":"阳普医疗","Url":"http://static.cninfo.com.cn/finalpage/2020-03-07/1207351515.PDF","MarketType":4,"NoticeType":"年度报告","Industry":"专用设备制造业","ParentIndustry":"制造业","Province":"","IntermediaryName":null,"IntermediaryType":0,"RelevantLaws":[],"Href":"/Home/FilingDetail?key=jp43Css5NBQ84UGPOG7XmHJljnSZJsFu3W8atHvXk13ZwOSBHeIriQ==&sector=1","ShareHref":null,"SourcePath":"a-filings/original/300030/2020-03-07 2019年年度报告摘要.PDF","TotalPage":0,"FileType":1,"Availability":1,"IsDir":0,"IsFav":false,"Preview":"股票代码：300030 \t股票简称：阳普医疗\t公告编号：2020-018债券代码：112522 \t债券简称：17阳普S1<br />&emsp;&emsp;广州阳普医疗科技股份有限公司 2019 年年度报告摘要<br />一、重要提示<br />本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投资者应当到证监会指定媒体仔细阅读年度报告全文。<br />立信会计师..."},"Highlight":{"Content":["@4@37@&emsp;&emsp;公司旗下的全资子公司广州惠侨计算机科技有限公司的发展战略：以“打造中国智慧医疗铁军”为愿景，立志构建智慧医疗产业生态链平台型公司，深耕智慧医疗行业，紧紧围绕<em>健康中国2030</em>的总体思想，顺应国家分级诊疗、互联互通、电子病历等级评审和智慧医院等级评审等政策需求，结合“云大物移智”新技术应用发展，充分利用行业积累和优势，持续通过“夯实基础，持续改进”的方式，不断推陈出新，进而实现智慧医疗信息化的行业领先地位。公司旨在提供真正以病人为中心、以医护为导向、以精益管理为目标的线上与线下相结合（O2O）的智慧医疗服务一体化解决方案，主要包括："],"Title":[],"Adjacent":[],"Diff":[],"HasMore":false,"Keywords":[]},"IOSHighlight":{"Content":[],"Title":[]},"KeywordFrequencies":[]}],"GroupKey":null,"GroupHits":[],"Aggregations":[{"AggKey":"companyCount","AggName":null,"Items":[{"N":"total","C":111,"M":0,"JsonTag":null}],"ItemList":[]},{"AggKey":"company","AggName":null,"Items":[{"N":"300147 香雪制药","C":5,"M":0,"JsonTag":null},{"N":"600257 大湖股份","C":3,"M":0,"JsonTag":null},{"N":"000503 国新健康","C":2,"M":0,"JsonTag":null},{"N":"000516 国际医学","C":2,"M":0,"JsonTag":null},{"N":"000590 启迪古汉","C":2,"M":0,"JsonTag":null},{"N":"000931 中关村","C":2,"M":0,"JsonTag":null},{"N":"002022 科华生物","C":2,"M":0,"JsonTag":null},{"N":"002044 美年健康","C":2,"M":0,"JsonTag":null},{"N":"002107 沃华医药","C":2,"M":0,"JsonTag":null},{"N":"002317 众生药业","C":2,"M":0,"JsonTag":null},{"N":"002566 益盛药业","C":2,"M":0,"JsonTag":null},{"N":"002589 瑞康医药","C":2,"M":0,"JsonTag":null},{"N":"002864 盘龙药业","C":2,"M":0,"JsonTag":null},{"N":"300030 阳普医疗","C":2,"M":0,"JsonTag":null},{"N":"300143 盈康生命","C":2,"M":0,"JsonTag":null},{"N":"300146 汤臣倍健","C":2,"M":0,"JsonTag":null},{"N":"300238 冠昊生物","C":2,"M":0,"JsonTag":null},{"N":"300247 融捷健康","C":2,"M":0,"JsonTag":null},{"N":"300273 和佳医疗","C":2,"M":0,"JsonTag":null},{"N":"300289 利德曼","C":2,"M":0,"JsonTag":null},{"N":"300439 美康生物","C":2,"M":0,"JsonTag":null},{"N":"300451 创业慧康","C":2,"M":0,"JsonTag":null},{"N":"300453 三鑫医疗","C":2,"M":0,"JsonTag":null},{"N":"300534 陇神戎发","C":2,"M":0,"JsonTag":null},{"N":"300562 乐心医疗","C":2,"M":0,"JsonTag":null},{"N":"300676 华大基因","C":2,"M":0,"JsonTag":null},{"N":"300765 新诺威","C":2,"M":0,"JsonTag":null},{"N":"600090 *ST济堂","C":2,"M":0,"JsonTag":null},{"N":"600381 青海春天","C":2,"M":0,"JsonTag":null},{"N":"600422 昆药集团","C":2,"M":0,"JsonTag":null},{"N":"600436 片仔癀","C":2,"M":0,"JsonTag":null},{"N":"600568 *ST中珠","C":2,"M":0,"JsonTag":null},{"N":"600572 康恩贝","C":2,"M":0,"JsonTag":null},{"N":"600587 新华医疗","C":2,"M":0,"JsonTag":null},{"N":"600645 中源协和","C":2,"M":0,"JsonTag":null},{"N":"600763 通策医疗","C":2,"M":0,"JsonTag":null},{"N":"600767 ST运盛","C":2,"M":0,"JsonTag":null},{"N":"600771 广誉远","C":2,"M":0,"JsonTag":null},{"N":"603127 昭衍新药","C":2,"M":0,"JsonTag":null},{"N":"603368 柳药股份","C":2,"M":0,"JsonTag":null},{"N":"603567 珍宝岛","C":2,"M":0,"JsonTag":null},{"N":"603669 灵康药业","C":2,"M":0,"JsonTag":null},{"N":"603676 卫信康","C":2,"M":0,"JsonTag":null},{"N":"603719 良品铺子","C":2,"M":0,"JsonTag":null},{"N":"603939 益丰药房","C":2,"M":0,"JsonTag":null},{"N":"603990 麦迪科技","C":2,"M":0,"JsonTag":null},{"N":"603998 方盛制药","C":2,"M":0,"JsonTag":null},{"N":"688089 嘉必优","C":2,"M":0,"JsonTag":null},{"N":"688310 迈得医疗","C":2,"M":0,"JsonTag":null},{"N":"000009 中国宝安","C":1,"M":0,"JsonTag":null},{"N":"000078 海王生物","C":1,"M":0,"JsonTag":null},{"N":"000639 西王食品","C":1,"M":0,"JsonTag":null},{"N":"000705 浙江震元","C":1,"M":0,"JsonTag":null},{"N":"000989 九芝堂","C":1,"M":0,"JsonTag":null},{"N":"000990 诚志股份","C":1,"M":0,"JsonTag":null},{"N":"000999 华润三九","C":1,"M":0,"JsonTag":null},{"N":"002016 世荣兆业","C":1,"M":0,"JsonTag":null},{"N":"002093 国脉科技","C":1,"M":0,"JsonTag":null},{"N":"002166 莱茵生物","C":1,"M":0,"JsonTag":null},{"N":"002262 恩华药业","C":1,"M":0,"JsonTag":null},{"N":"002294 信立泰","C":1,"M":0,"JsonTag":null},{"N":"002411 延安必康","C":1,"M":0,"JsonTag":null},{"N":"002424 贵州百灵","C":1,"M":0,"JsonTag":null},{"N":"002433 太安堂","C":1,"M":0,"JsonTag":null},{"N":"002582 好想你","C":1,"M":0,"JsonTag":null},{"N":"002603 以岭药业","C":1,"M":0,"JsonTag":null},{"N":"002614 奥佳华","C":1,"M":0,"JsonTag":null},{"N":"002644 佛慈制药","C":1,"M":0,"JsonTag":null},{"N":"300003 乐普医疗","C":1,"M":0,"JsonTag":null},{"N":"300009 安科生物","C":1,"M":0,"JsonTag":null},{"N":"300096 易联众","C":1,"M":0,"JsonTag":null},{"N":"300122 智飞生物","C":1,"M":0,"JsonTag":null},{"N":"300149 量子生物","C":1,"M":0,"JsonTag":null},{"N":"300216 千山退","C":1,"M":0,"JsonTag":null},{"N":"300239 东宝生物","C":1,"M":0,"JsonTag":null},{"N":"300249 依米康","C":1,"M":0,"JsonTag":null},{"N":"300253 卫宁健康","C":1,"M":0,"JsonTag":null},{"N":"300298 三诺生物","C":1,"M":0,"JsonTag":null},{"N":"300314 戴维医疗","C":1,"M":0,"JsonTag":null},{"N":"300396 迪瑞医疗","C":1,"M":0,"JsonTag":null},{"N":"300479 神思电子","C":1,"M":0,"JsonTag":null},{"N":"300605 恒锋信息","C":1,"M":0,"JsonTag":null},{"N":"300639 凯普生物","C":1,"M":0,"JsonTag":null},{"N":"300791 仙乐健康","C":1,"M":0,"JsonTag":null},{"N":"600080 ST金花","C":1,"M":0,"JsonTag":null},{"N":"600085 同仁堂","C":1,"M":0,"JsonTag":null},{"N":"600161 天坛生物","C":1,"M":0,"JsonTag":null},{"N":"600222 太龙药业","C":1,"M":0,"JsonTag":null},{"N":"600223 鲁商发展","C":1,"M":0,"JsonTag":null},{"N":"600272 开开实业","C":1,"M":0,"JsonTag":null},{"N":"600285 羚锐制药","C":1,"M":0,"JsonTag":null},{"N":"600380 健康元","C":1,"M":0,"JsonTag":null},{"N":"600479 千金药业","C":1,"M":0,"JsonTag":null},{"N":"600521 华海药业","C":1,"M":0,"JsonTag":null},{"N":"600530 *ST交昂","C":1,"M":0,"JsonTag":null},{"N":"600538 国发股份","C":1,"M":0,"JsonTag":null},{"N":"600750 江中药业","C":1,"M":0,"JsonTag":null},{"N":"600781 *ST辅仁","C":1,"M":0,"JsonTag":null},{"N":"600976 健民集团","C":1,"M":0,"JsonTag":null},{"N":"600998 九州通","C":1,"M":0,"JsonTag":null},{"N":"601601 中国太保","C":1,"M":0,"JsonTag":null},{"N":"603139 康惠制药","C":1,"M":0,"JsonTag":null},{"N":"603168 莎普爱思","C":1,"M":0,"JsonTag":null},{"N":"603233 大参林","C":1,"M":0,"JsonTag":null},{"N":"603711 香飘飘","C":1,"M":0,"JsonTag":null},{"N":"603739 蔚蓝生物","C":1,"M":0,"JsonTag":null},{"N":"603858 步长制药","C":1,"M":0,"JsonTag":null},{"N":"603896 寿仙谷","C":1,"M":0,"JsonTag":null},{"N":"603987 康德莱","C":1,"M":0,"JsonTag":null},{"N":"688016 心脉医疗","C":1,"M":0,"JsonTag":null},{"N":"688029 南微医学","C":1,"M":0,"JsonTag":null}],"ItemList":[]}],"HighlightFilters":[{"Keyword":"健康中国2030","IsApplied":false}],"TitleHighlights":[],"ContentHighlights":[],"IpoItems":[],"Message":null,"NickName":null,"PaymentStatus":"1","SubscriptionLimit":"20","CanPay":true,"ExpireTime":"2021-08-29","ResponseCode":100,"ResponseMessage":"","Token":"nmRnY1j%2bCGXKCM4bM4TTn3jQHDvW7eGIToGnu4ZfJe7o87Tw1S6SoYeBvRf7P4zvFXODclaHtVxIRE7b0lMXAdV6YpyuqxpGH84D1n0f2sR6vD%2bBGy45OvR6KoTmHezOaKkH6pr2ZE6g%2fpE%2bXsF1WQ%3d%3d","CommonSession":null}